Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: current progress and novel strategies
D Li, X Peng, Z Hu, S Li, J Chen, W Pan - European journal of medicinal …, 2024 - Elsevier
Histone methyltransferases (HMTs) play a critical role in gene post-translational regulation
and diverse physiological processes, and are implicated in a plethora of human diseases …
and diverse physiological processes, and are implicated in a plethora of human diseases …
Exploring the potential of histone demethylase inhibition in multi-therapeutic approaches for cancer treatment
D Li, H Liang, Y Wei, H Xiao, X Peng, W Pan - European Journal of …, 2024 - Elsevier
Histone demethylases play a critical role in gene transcription regulation and have been
implicated in cancer. Numerous reports have highlighted the overexpression of histone …
implicated in cancer. Numerous reports have highlighted the overexpression of histone …
[HTML][HTML] Glycogen synthase kinase-3: A potential immunotherapeutic target in tumor microenvironment
J Liang, M Yu, Y Li, L Zhao, Q Wei - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Abstract Glycogen synthase kinase-3 (GSK-3) is a protein kinase that can phosphorylate
over a hundred substrates and regulate cell differentiation, proliferation, and death …
over a hundred substrates and regulate cell differentiation, proliferation, and death …
Overview of the Epigenetic/Cytotoxic Dual-Target Inhibitors for Cancer Therapy
H Liang, S Li, X Peng, H Xiao - European Journal of Medicinal Chemistry, 2025 - Elsevier
Epigenetic dysregulation plays a pivotal role in the initiation and progression of various
cancers, influencing critical processes such as tumor growth, invasion, migration, survival …
cancers, influencing critical processes such as tumor growth, invasion, migration, survival …
GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms
AÉ Silva-Carvalho, LDC Filiú-Braga, GMR Bogéa… - Cancer Cell …, 2024 - Springer
Histone methyltransferases (HMTs) are enzymes that regulate histone methylation and play
an important role in controlling transcription by altering the chromatin structure. Aberrant …
an important role in controlling transcription by altering the chromatin structure. Aberrant …
The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update
H Zhou, J Gui, L Zhu, Y Mi - OncoTargets and Therapy, 2024 - Taylor & Francis
Methylation-mediated gene silencing is closely related to the occurrence and development
of human tumors. The euchromatic histone lysine methyltransferase 2 (EHMT2, also known …
of human tumors. The euchromatic histone lysine methyltransferase 2 (EHMT2, also known …
Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer's Agent
A Jana, A Bellver-Sanchis, C Griñán-Ferré… - ACS Medicinal …, 2023 - ACS Publications
Herein, we report for the first time the G9a/EHMT2 inhibition and anti-Alzheimer's activities of
the drug raltitrexed. G9a is a lysine methyltransferase that mainly dimethylates the H3K9 of …
the drug raltitrexed. G9a is a lysine methyltransferase that mainly dimethylates the H3K9 of …
SETDB1 targeting SESN2 regulates mitochondrial damage and oxidative stress in renal ischemia–reperfusion injury
K Xia, Y Hui, L Zhang, Q Qiu, J Zhong, H Chen, X Liu… - BMC biology, 2024 - Springer
Background The role of histone methyltransferase SETDB1 in renal ischemia–reperfusion
(I/R) injury has not been explored yet. This study aims to investigate the potential …
(I/R) injury has not been explored yet. This study aims to investigate the potential …
How CBX proteins regulate normal and leukemic blood cells
AP de Groot, G de Haan - FEBS letters, 2024 - Wiley Online Library
Hematopoietic stem cell (HSC) fate decisions are dictated by epigenetic landscapes. The
Polycomb Repressive Complex 1 (PRC1) represses genes that induce differentiation …
Polycomb Repressive Complex 1 (PRC1) represses genes that induce differentiation …
Targeting leukemia-initiating cells and leukemic niches: the next therapy station for T-cell acute lymphoblastic leukemia?
Z Zhang, K Yang, H Zhang - Cancers, 2022 - mdpi.com
Simple Summary T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy
arising from the aberrant proliferation of immature T-cell progenitors. Despite improved …
arising from the aberrant proliferation of immature T-cell progenitors. Despite improved …